Axon president granted 67,910 performance stock units

AXON ENTERPRISE, INC. president Joshua Isner reported equity compensation activity.

Rhea-AI Filing Summary

AXON ENTERPRISE, INC. president Joshua Isner reported equity compensation activity. On August 16, 2026 he acquired 67,910 performance-based restricted stock units (XSUs) tied to a tranche under the 2024 eXponential Stock Plan whose performance conditions were certified, which will vest on December 1, 2026 and then be subject to a minimum holding period. He also received a supplemental equity grant of 14,218 shares. On August 13, 2026, 15,704.08 shares were withheld at $615.59 per share to settle tax liabilities from vesting restricted stock units.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Isner Joshua

Role PRESIDENT

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F2	67,910	$0.00	$0.00
Grant/Award	Common Stock F3	14,218	$0.00	$0.00
Tax Withholding	Common Stock F1	15,704.08	$615.59	$9.67M

Holdings After Transaction: Common Stock — 313,748.549 shares (Direct)

Footnotes (3)

1. F1. Securities disposed represent securities withheld to settle the reporting person's tax liability resulting from the vesting of restricted stock units.
2. F2. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.
3. F3. This award represents a supplemental grant approved by the Compensation Committee to implement the executive compensation program as intended with respect to the treatment of future XSP tranches.

Key Figures

Performance-based XSUs certified tranche: 67,910 shares Supplemental grant: 14,218 shares Tax withholding shares: 15,704.08 shares +4 more

7 metrics

Performance-based XSUs certified tranche 67,910 shares Common stock underlying XSUs for fourth tranche certified on August 16, 2026

Supplemental grant 14,218 shares Supplemental equity award approved by Compensation Committee

Tax withholding shares 15,704.08 shares Shares withheld on August 13, 2026 to settle tax liability

Tax withholding price $615.59 per share Per-share value for 15,704.08 withheld shares used for tax settlement

XSUs grant date December 22, 2023 Original grant date of performance-based XSUs under 2024 eXponential Stock Plan

XSUs vesting date December 1, 2026 Vesting date for the certified XSUs tranche, subject to continued employment

Minimum holding period end December 31, 2030 Latest date for minimum holding period on shares deliverable for the XSUs tranche

Key Terms

performance-based restricted stock units, eXponential Stock Plan, restricted stock units, minimum holding period

4 terms

performance-based restricted stock units financial

"The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted"

Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.

eXponential Stock Plan financial

"pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan"

restricted stock units financial

"tax liability resulting from the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

minimum holding period financial

"shares deliverable for the Tranche are subject to a minimum holding period"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did AXON (AXON) president Joshua Isner report on August 16, 2026?

Joshua Isner reported acquiring 67,910 performance-based restricted stock units (XSUs) from a certified tranche and a supplemental grant of 14,218 shares. These awards are part of Axon’s executive compensation program and are subject to future vesting and holding conditions.

When will Joshua Isner’s 67,910 AXON performance-based XSUs vest and be restricted?

The 67,910 performance-based XSUs will vest on December 1, 2026, subject to continued employment. After vesting, the delivered shares face a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent XSUs tranche, excluding tax-related shares.

What is the nature of the 14,218-share supplemental grant reported by AXON’s president?

The 14,218-share award is a supplemental grant approved by the Compensation Committee. It is intended to implement Axon’s executive compensation program as designed with respect to the treatment of future eXponential Stock Plan (XSP) tranches for Joshua Isner.

Why were 15,704.08 AXON shares disposed of at $615.59 in Joshua Isner’s Form 4?

The 15,704.08 shares, priced at $615.59 per share, were withheld to settle tax liabilities arising from the vesting of restricted stock units. This is a non-market disposition used to satisfy withholding obligations rather than an open-market sale.

Were Joshua Isner’s August 2026 AXON transactions made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as using such a plan, and the footnotes describe equity awards and tax withholding mechanics only. There is no indication these specific transactions were executed pursuant to a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 05:28 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Isner Joshua

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2026		F(1)		15,704.08	D	$615.59	231,620.549	D
Common Stock	08/16/2026		A(2)		67,910	A	$0	299,530.549	D
Common Stock	08/16/2026		A(3)		14,218	A	$0	313,748.549	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Securities disposed represent securities withheld to settle the reporting person's tax liability resulting from the vesting of restricted stock units.

2. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

3. This award represents a supplemental grant approved by the Compensation Committee to implement the executive compensation program as intended with respect to the treatment of future XSP tranches.

Remarks:

	/s/ Joshua Isner, by Isaiah Fields, Attorney-in-Fact	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)